Merger of Invitrogen, Applied Biosystems could close Nov. 21

By Lisa Kerner

Charlotte, N.C., Nov. 11 - The pending merger of Invitrogen Corp. and Applied Biosystems Inc. is expected to close on Nov. 21 now that the European Commission has approved the transaction.

The last day for Applied Biosystems stockholders to elect their merger consideration is Nov. 19, an Invitrogen news release said.

In June, Invitrogen agreed to acquire Applied Biosystems for $38 per share in a cash-and-stock transaction valued at $6.7 billion.

Invitrogen is a Carlsbad, Calif.-based provider of life science technologies for disease research, drug discovery and commercial bioproduction.

Applied Biosystems is a developer and marketer of instrument-based systems, consumables, software and services. The company is located in Norwalk, Conn.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.